PDF(Pubmed)
Abstract：
UNASSIGNED: Although conventional transurethral resection of the prostate (TURP) is highly successful in improving urinary symptoms and flow rates, a higher incidence of loss of antegrade ejaculation has been reported. Therefore, we aimed at prospectively comparing the efficacy and outcomes of a novel dual bladder neck and supramontanal sparing TURP to conventional TURP to improve voiding and ejaculation.
UNASSIGNED: Between January 2019 and November 2020, all patients with benign prostatic hyperplasia (BPH) satisfying the eligibility criteria underwent either conventional TURP (Group 1) or combined bladder neck and supramontanal sparing TURP (Group 2) after randomisation. The groups were compared for functional outcomes including International Prostate Symptom Score (IPSS), peak flow rates, post-void residual urine, perioperative variables and postoperative complications. Ejaculation was assessed with International Index of Erectile Function-Question 9 (IIEF-9) and Ejaculation Projection score (EPS).
UNASSIGNED: A total of 90 patients were randomised, 45 each to Group 1 and 2 respectively. The demographic profiles across both groups were comparable. Retrograde ejaculation and bladder neck contracture were significantly higher in Group 1. Both groups demonstrated significant improvement in the IPSS (26.12 ±2.88 to 4.69 ±0.87 (Group 1) vs 26.60 ±3.45 to 4.36 ±1.74 in Group 2) and Qmax (7.03 ±2.71 to 24.36 ±3.82 mL/s in Group 1 vs 6.29 ±2.64 to 25.28 ±4.33 mL/s in Group 2) at 3 months. However, a significant difference in IPSS and Qmax were recorded at 6 months. IIEF-9 score in Group 2 remained similar to preoperative profile (4.18 ±0.75) vs 2.58 ±0.86 (Group 1). EPS significantly decreased in Group 1 but remained similar to preoperative EPS in Group 2. Antegrade ejaculation was preserved in 88.89% in Group 2 as compared to 22.22% in Group 1.
UNASSIGNED: Dual bladder neck and supramontanal ejaculation preserving TURP is superior to conventional TURP in preventing retrograde ejaculation and bladder neck contractures in prostates <50 cc with comparable functional results, perioperative and postoperative morbidity.
UNASSIGNED: Between January 2019 and November 2020, all patients with benign prostatic hyperplasia (BPH) satisfying the eligibility criteria underwent either conventional TURP (Group 1) or combined bladder neck and supramontanal sparing TURP (Group 2) after randomisation. The groups were compared for functional outcomes including International Prostate Symptom Score (IPSS), peak flow rates, post-void residual urine, perioperative variables and postoperative complications. Ejaculation was assessed with International Index of Erectile Function-Question 9 (IIEF-9) and Ejaculation Projection score (EPS).
UNASSIGNED: A total of 90 patients were randomised, 45 each to Group 1 and 2 respectively. The demographic profiles across both groups were comparable. Retrograde ejaculation and bladder neck contracture were significantly higher in Group 1. Both groups demonstrated significant improvement in the IPSS (26.12 ±2.88 to 4.69 ±0.87 (Group 1) vs 26.60 ±3.45 to 4.36 ±1.74 in Group 2) and Qmax (7.03 ±2.71 to 24.36 ±3.82 mL/s in Group 1 vs 6.29 ±2.64 to 25.28 ±4.33 mL/s in Group 2) at 3 months. However, a significant difference in IPSS and Qmax were recorded at 6 months. IIEF-9 score in Group 2 remained similar to preoperative profile (4.18 ±0.75) vs 2.58 ±0.86 (Group 1). EPS significantly decreased in Group 1 but remained similar to preoperative EPS in Group 2. Antegrade ejaculation was preserved in 88.89% in Group 2 as compared to 22.22% in Group 1.
UNASSIGNED: Dual bladder neck and supramontanal ejaculation preserving TURP is superior to conventional TURP in preventing retrograde ejaculation and bladder neck contractures in prostates <50 cc with comparable functional results, perioperative and postoperative morbidity.
摘要：
■尽管传统的经尿道前列腺电切术（TURP）在改善泌尿症状和流速方面非常成功，据报道，顺行射精丢失的发生率较高。因此,我们的目的是前瞻性比较新型膀胱颈和阴部上双保留TURP与常规TURP的疗效和结局,以改善排尿和射精.
■在2019年1月至2020年11月之间，所有符合资格标准的良性前列腺增生（BPH）患者在随机分组后接受了常规TURP（第1组）或联合膀胱颈和输卵管上保留TURP（第2组）。比较两组的功能结局，包括国际前列腺症状评分（IPSS），峰值流速,排尿后残留尿液，围手术期变量和术后并发症。使用国际勃起功能指数-问题9（IIEF-9）和射精投影评分（EPS）评估射精。
■共有90名患者被随机分组，45个分别为第1组和第2组。两组的人口统计学特征具有可比性。第1组逆行射精和膀胱颈挛缩明显增高。两组在3个月时IPSS（26.12±2.88至4.69±0.87（第1组）vs第2组的26.60±3.45至4.36±1.74）和Qmax（第1组的7.03±2.71至24.36±3.82mL/svs第2组的6.29±2.64至25.28±4.33mL/s）均有显着改善。然而,在6个月时,IPSS和Qmax有显著差异.第2组的IIEF-9评分与术前相似（4.18±0.75）和2.58±0.86（第1组）。第1组的EPS显着下降，但与第2组的术前EPS相似。与第1组的22.22％相比，第2组的顺行射精保留率为88.89％。
■双膀胱颈和阴部射精保留TURP在防止前列腺<50cc的逆行射精和膀胱颈挛缩方面优于常规TURP，具有相当的功能效果。围手术期和术后发病率。
■在2019年1月至2020年11月之间，所有符合资格标准的良性前列腺增生（BPH）患者在随机分组后接受了常规TURP（第1组）或联合膀胱颈和输卵管上保留TURP（第2组）。比较两组的功能结局，包括国际前列腺症状评分（IPSS），峰值流速,排尿后残留尿液，围手术期变量和术后并发症。使用国际勃起功能指数-问题9（IIEF-9）和射精投影评分（EPS）评估射精。
■共有90名患者被随机分组，45个分别为第1组和第2组。两组的人口统计学特征具有可比性。第1组逆行射精和膀胱颈挛缩明显增高。两组在3个月时IPSS（26.12±2.88至4.69±0.87（第1组）vs第2组的26.60±3.45至4.36±1.74）和Qmax（第1组的7.03±2.71至24.36±3.82mL/svs第2组的6.29±2.64至25.28±4.33mL/s）均有显着改善。然而,在6个月时,IPSS和Qmax有显著差异.第2组的IIEF-9评分与术前相似（4.18±0.75）和2.58±0.86（第1组）。第1组的EPS显着下降，但与第2组的术前EPS相似。与第1组的22.22％相比，第2组的顺行射精保留率为88.89％。
■双膀胱颈和阴部射精保留TURP在防止前列腺<50cc的逆行射精和膀胱颈挛缩方面优于常规TURP，具有相当的功能效果。围手术期和术后发病率。
